Form 4: Quanterix CFO Executes Routine RSU Vesting
Statement of Changes in Beneficial Ownership
Quanterix Corporation CFO Vandana Sriram completed a routine conversion of restricted stock units into common stock.
Summary
- Vandana Sriram, Chief Financial Officer of Quanterix Corporation, acquired 1,833 shares of common stock through the vesting of restricted stock units (RSUs).
- A total of 548 shares were withheld by the company to satisfy tax obligations at a price of $3.60 per share.
- The net increase in the CFO's direct beneficial ownership was 1,285 shares.
- The transactions occurred on April 15, 2026, as part of a pre-existing equity compensation plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents routine administrative equity vesting rather than a strategic or market-moving development.
Positives
- The transaction reflects standard equity-based compensation alignment between the executive and shareholders.
- The CFO maintains a significant direct ownership stake of 28,713 shares following the transaction.
Negatives
- The filing indicates a tax-related sell-to-cover transaction, which is a standard administrative procedure rather than a market-driven divestment.
Risks
- The company remains subject to standard market risks associated with the biotechnology and life sciences sector.
Future Outlook
The filing does not provide forward-looking financial guidance, as it is a routine disclosure of insider equity transactions.
Management Comments
- No narrative comments were provided by management in this filing.
Industry Context
StockSavvy.ai notes that this filing is a standard regulatory disclosure for executive compensation and does not signal a change in corporate strategy or financial outlook.
Comparison to Industry Standards
- The use of 'sell-to-cover' for tax obligations is a standard industry practice for executive equity compensation.
- The vesting schedule aligns with typical multi-year retention programs seen in the biotechnology sector.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a routine component of executive compensation.
Next Steps
- Continued periodic vesting of remaining RSU tranches as per the established schedule.
Key Dates
| Date | Description |
|---|---|
| 08/21/2023 | Initial grant date of RSU tranche and execution of Power of Attorney. |
| 02/02/2024 | Initial grant date of second RSU tranche. |
| 02/04/2025 | Initial grant date of third RSU tranche. |
| 04/15/2026 | Transaction date for RSU vesting and tax withholding. |
| 04/16/2026 | Filing date of the Form 4. |
Keywords
Quanterix, QTRX, CFO, Insider Trading, Equity Compensation, Restricted Stock Units, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.